Valion Bio, Inc. (VBIO) stock

VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30

$0.53+0.02 (+4.05%)

Close on Nov 13, 2026Market cap $2.20MP/E –Yield –

Valion Bio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Valion Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?